Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
5.30
-2.54 (-32.40%)
At close: Nov 6, 2025, 4:00 PM EST
5.41
+0.11 (2.08%)
After-hours: Nov 6, 2025, 4:55 PM EST
Genelux Market Cap
Genelux has a market cap or net worth of $197.9 million as of November 6, 2025. Its market cap has increased by 118.99% in one year.
Market Cap
197.90M
Enterprise Value
184.96M
1-Year Change
118.99%
Ranking
Category
Stock Price
$5.30
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has increased from $141.69M to $197.90M, an increase of 39.67%. That is a compound annual growth rate of 12.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 292.75M | 263.72% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 828.96B |
| Johnson & Johnson | 448.13B |
| AbbVie | 383.12B |
| UnitedHealth Group | 296.88B |
| AstraZeneca | 251.76B |
| Novartis AG | 240.29B |
| Abbott Laboratories | 216.56B |
| Thermo Fisher Scientific | 213.27B |